Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lleo

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|November 28, 2012
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisRichy C Y Chen, Phornnop Naiyanetr, Shang-An Shu, et al.
Journal of Autoimmunity|July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patientsLorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
The Lancet Regional Health. Europe|March 17, 2025
Mapping the landscape of biliary tract cancer in Europe: challenges and controversiesLorenza Rimassa, Shahid Khan, Bas Groot Koerkamp, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Journal of Autoimmunity|October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosisHaiying Liu, Gary L Norman, Zakera Shums, et al.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2025
Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre StudyFrancesca Colapietro, Mauro Viganò, Federica Cerini, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|November 28, 2012
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisRichy C Y Chen, Phornnop Naiyanetr, Shang-An Shu, et al.
Journal of Autoimmunity|July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patientsLorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
The Lancet Regional Health. Europe|March 17, 2025
Mapping the landscape of biliary tract cancer in Europe: challenges and controversiesLorenza Rimassa, Shahid Khan, Bas Groot Koerkamp, et al.
Nature Reviews. Gastroenterology & Hepatology|February 19, 2026
The ethics of unlicensed therapy use in primary biliary cholangitis: a counter viewDavid E J Jones, Robert Mitchell-Thain, Emma L Culver, et al.
Journal of Autoimmunity|October 12, 2010
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosisHaiying Liu, Gary L Norman, Zakera Shums, et al.
Gut|September 1, 2025
Immunosuppressive contribution of tumour-infiltrating B cells in human intrahepatic cholangiocarcinoma and their role in chemoimmunotherapy outcomeGiulia Milardi, Barbara Franceschini, Chiara Camisaschi, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 1, 2025
Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre StudyFrancesca Colapietro, Mauro Viganò, Federica Cerini, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Pageof 21